exonucleasefamily surface anchored protein Inhibitors
The chemical class termed exonucleasefamily surface anchored protein Inhibitors comprises a range of antibiotics capable of potentially inhibiting the function of the exonucleasefamily surface anchored protein by targeting essential bacterial processes. These antibiotics exert their inhibitory effects through various mechanisms, including interference with DNA replication, transcription, translation, and cell wall synthesis, ultimately affecting bacterial viability. For instance, antibiotics like ciprofloxacin and rifampicin target bacterial enzymes involved in DNA replication and RNA synthesis, respectively, leading to disruption of essential cellular processes and potentially interfering with the function of the exonucleasefamily surface anchored protein.
Furthermore, antibiotics such as tetracycline and chloramphenicol inhibit protein synthesis by binding to the bacterial ribosome, thereby impairing the production of essential proteins, including the protein of interest. Additionally, antibiotics like trimethoprim and vancomycin disrupt bacterial metabolism and cell wall synthesis, leading to cell death and potential impairment of the protein's function within the bacterial cell. Overall, the diverse mechanisms of action exhibited by these antibiotics highlight their potential as inhibitors of the exonucleasefamily surface anchored protein, offering valuable insights into potential strategies for targeting this protein in bacterial pathogens. Further research into the specific interactions between these antibiotics and the protein of interest will enhance our understanding of their inhibitory effects and their potential applications in combating bacterial infections.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ciprofloxacin | 85721-33-1 | sc-217900 | 1 g | $43.00 | 8 | |
Ciprofloxacin is a broad-spectrum antibiotic that can potentially inhibit the exonucleasefamily surface anchored protein by targeting bacterial DNA gyrase and topoisomerase IV. Inhibition of these enzymes can lead to DNA damage and disruption of bacterial replication, ultimately interfering with the function of the protein. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin is an antibiotic that can potentially inhibit the exonucleasefamily surface anchored protein by targeting bacterial RNA polymerase. Inhibition of RNA synthesis can lead to the downregulation of essential bacterial proteins, potentially including the protein of interest, thereby interfering with its function within the bacterial cell. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline is a broad-spectrum antibiotic that can potentially inhibit the exonucleasefamily surface anchored protein by binding to the bacterial ribosome and inhibiting protein synthesis. This disruption in protein production can lead to impaired function of the protein of interest, ultimately affecting bacterial viability. | ||||||
Novobiocin | 303-81-1 | sc-362034 sc-362034A | 5 mg 25 mg | $128.00 $380.00 | ||
Novobiocin is an antibiotic that can potentially inhibit the exonucleasefamily surface anchored protein by targeting bacterial DNA gyrase. Inhibition of DNA gyrase activity can lead to DNA damage and interference with DNA replication, potentially affecting the function of the protein within the bacterial cell. | ||||||
Metronidazole | 443-48-1 | sc-204805 sc-204805A | 5 g 25 g | $84.00 $205.00 | 11 | |
Metronidazole is an antibiotic that can potentially inhibit the exonucleasefamily surface anchored protein by causing DNA damage through the generation of reactive oxygen species (ROS) within bacterial cells. This DNA damage can lead to disruption of essential cellular processes, ultimately affecting protein function. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
Chloramphenicol is an antibiotic that can potentially inhibit the exonucleasefamily surface anchored protein by binding to the bacterial ribosome and inhibiting protein synthesis. Inhibition of protein production can lead to impaired function of the protein of interest, ultimately affecting bacterial viability. | ||||||
Trimethoprim | 738-70-5 | sc-203302 sc-203302A sc-203302B sc-203302C sc-203302D | 5 g 25 g 250 g 1 kg 5 kg | $67.00 $161.00 $255.00 $721.00 $3401.00 | 4 | |
Trimethoprim is an antibiotic that can potentially inhibit the exonucleasefamily surface anchored protein by inhibiting bacterial dihydrofolate reductase (DHFR), an enzyme involved in folate metabolism. Inhibition of DHFR disrupts the production of essential cofactors, potentially affecting the function of the protein within the bacterial cell. | ||||||
Nitrofurantoin | 67-20-9 | sc-212399 | 10 g | $84.00 | ||
Nitrofurantoin is an antibiotic that can potentially inhibit the exonucleasefamily surface anchored protein by causing damage to bacterial DNA. This damage disrupts essential cellular processes, potentially affecting the function of the protein within the bacterial cell and ultimately leading to bacterial death. | ||||||
Clindamycin | 18323-44-9 | sc-337636A sc-337636B sc-337636C sc-337636 | 25 mg 50 mg 100 mg 1 g | $156.00 $374.00 $572.00 $825.00 | 2 | |
Clindamycin is an antibiotic that can potentially inhibit the exonucleasefamily surface anchored protein by binding to the bacterial ribosome and inhibiting protein synthesis. Inhibition of protein production can lead to impaired function of the protein of interest, ultimately affecting bacterial viability. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $57.00 $245.00 $831.00 $1331.00 | 4 | |
Erythromycin is an antibiotic that can potentially inhibit the exonucleasefamily surface anchored protein by binding to the bacterial ribosome and inhibiting protein synthesis. Inhibition of protein production can lead to impaired function of the protein of interest, ultimately affecting bacterial viability. | ||||||